Skip to main content
. Author manuscript; available in PMC: 2017 Oct 3.
Published in final edited form as: J Neurosurg. 2017 Jan 6;127(4):905–916. doi: 10.3171/2016.9.JNS1627

TABLE 1.

Experimental design for the current study

Group No Preinfusion IPH Preinfused Experimental Phase*
IPH Total T2 Map T1 Enhancement T1/T2 Volume
Controls 57 4 8 0 65 65 52 15
VEGF (ng/hr)
 Low-dose (2) 80 5 8 0 88 88 45 15
 Medium-dose (10) 23 16 4 0 27
 High-dose (20) 2 2 0 0 2
 Single injection (100 ng) 3 0
*

MRI data was analyzed from images obtained from animal numbers listed in the 3 columns on the right.